Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in west nile virus encephalitis

Journal of Immunology

Volumn 186, Issue 1, 2011, Pages 471-478

  Lim, Jean K ^a   Obara, Christopher J ^a   Rivollier, Aymeric ^a   Pletnev, Alexander G ^a   Kelsall, Brian L ^a   Murphy, Philip M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL SURVIVAL; CELL TRANSFER; CELL TYPE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC DISORDER; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEUKOCYTE; MONOCYTE; MONOCYTOPENIA; MONOCYTOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS ENCEPHALITIS; WEST NILE FLAVIVIRUS;

ANIMALS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; HUMANS; LEUKOCYTOSIS; LEUKOPENIA; LIGANDS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; RECEPTORS, CCR2; VERO CELLS; VIRAL LOAD; WEST NILE FEVER; WEST NILE VIRUS;

EID: 79251586837     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003003     Document Type: Article

References (38)

1. Hayes, E. B., and D. J. Gubler. 2006. West Nile virus: epidemiology and clinical features of an emerging epidemic in the nited States. Annu. Rev. Med. 57: 181-194.
2. Glass, W. G., J. K. Lim, R. Cholera, A. G. Pletnev, J. L. Gao, and P. M. Murphy. 2005. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 202: 1087-1098.
3. Kelley, T. W., R. A. Prayson, A. I. Ruiz, C. M. Isada, and S. M. Gordon. 2003. The neuropathology of West Nile virus meningoencephalitis. A report of two cases and review of the literature. Am. J. Clin. Pathol. 119: 749-753.
4. Klein, R. S., E. Lin, B. Zhang, A. D. Luster, J. Tollett, M. A. Samuel, M. Engle, and M. S. Diamond. 2005. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 79: 11457-11466.
5. Sampson, B. A., C. Ambrosi, A. Charlot, K. Reiber, J. F. Veress, and V. Armbrustmacher. 2000. The pathology of human West Nile virus infection. Hum. Pathol. 31: 527-531.
6. Lim, J. K., W. G. Glass, D. H. McDermott, and P. M. Murphy. 2006. CCR5: no longer a "good for nothing" gene - chemokine control of West Nile virus infection. Trends Immunol. 27: 308-312.
7. Glass, W. G., D. H. McDermott, J. K. Lim, S. Lekhong, S. F. Yu, W. A. Frank, J. Pape, R. C. Cheshier, and P. M. Murphy. 2006. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 203: 35-40.
8. Lim, J. K., C. Y. Louie, C. Glaser, C. Jean, B. Johnson, H. Johnson, D. H. McDermott, and P. M. Murphy. 2008. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. J. Infect. Dis. 197: 262-265.
9. Lim, J. K., D. H. McDermott, A. Lisco, G. A. Foster, D. Krysztof, D. Follmann, S. L. Stramer, and P. M. Murphy. 2010. CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. J. Infect. Dis. 201: 178-185.
10. Zhang, B., Y. K. Chan, B. Lu, M. S. Diamond, and R. S. Klein. 2008. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J. Immunol. 180: 2641-2649.
11. Shrestha, B., M. A. Samuel, and M. S. Diamond. 2006. CD8+ T cells require perforin to clear West Nile virus from infected neurons. J. Virol. 80: 119-129.
12. McCandless, E. E., B. Zhang, M. S. Diamond, and R. S. Klein. 2008. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc. Natl. Acad. Sci. USA 105: 11270-11275.
13. Eltayeb, S., A. L. Berg, H. Lassmann, E. Wallström, M. Nilsson, T. Olsson, A. Ericsson-Dahlstrand, and D. Sunnemark. 2007. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. J. Neuroinflammation 4: 14.
14. Getts, D. R., R. L. Terry, M. T. Getts, M. Müller, S. Rana, B. Shrestha, J. Radford, N. Van Rooijen, I. L. Campbell, and N. J. King. 2008. Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J. Exp. Med. 205: 2319-2337.
15. Ben-Nathan, D., I. Huitinga, S. Lustig, N. van Rooijen, and D. Kobiler. 1996. West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice. Arch. Virol. 141: 459-469.
16. Tacke, F., and G. J. Randolph. 2006. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211: 609-618.
17. Jia, T., N. V. Serbina, K. Brandl, M. X. Zhong, I. M. Leiner, I. F. Charo, and E. G. Pamer. 2008. Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. J. Immunol. 180: 6846-6853.
18. Serbina, N. V., and E. G. Pamer. 2006. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7: 311-317.
19. Huffnagle, G. B., T. R. Traynor, R. A. McDonald, M. A. Olszewski, D. M. Lindell, A. C. Herring, and G. B. Toews. 2000. Leukocyte recruitment during pulmonary Cryptococcus neoformans infection. Immunopharmacology 48: 231-236.
20. Traynor, T. R., W. A. Kuziel, G. B. Toews, and G. B. Huffnagle. 2000. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164: 2021-2027.
21. Peters, W., H. M. Scott, H. F. Chambers, J. L. Flynn, I. F. Charo, and J. D. Ernst. 2001. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 98: 7958-7963.
22. Scott, H. M., and J. L. Flynn. 2002. Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression. Infect. Immun. 70: 5946-5954.
23. Contractor, N., J. Louten, L. Kim, C. A. Biron, and B. L. Kelsall. 2007. Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J. Immunol. 179: 2690-2694.
24. Mach, N., S. Gillessen, S. B. Wilson, C. Sheehan, M. Mihm, and G. Dranoff. 2000. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res. 60: 3239-3246.
25. Tsou, C. L., W. Peters, Y. Si, S. Slaymaker, A. M. Aslanian, S. P. Weisberg, M. Mack, and I. F. Charo. 2007. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117: 902-909.
26. Block, M. L., L. Zecca, and J. S. Hong. 2007. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8: 57-69.
27. Chao, C. C., S. Hu, T. W. Molitor, E. G. Shaskan, and P. K. Peterson. 1992. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149: 2736-2741.
28. Dougherty, K. D., C. F. Dreyfus, and I. B. Black. 2000. Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury. Neurobiol. Dis. 7(6 Pt B): 574-585.
29. Richardson, P. M., and X. Lu. 1994. Inflammation and axonal regeneration. J. Neurol. 242(1, Suppl 1): S57-S60.
30. Smith, M. E. 2001. Phagocytic properties of microglia in vitro: implications for a role in multiple sclerosis and EAE. Microsc. Res. Tech. 54: 81-94.
31. Yin, Y., Q. Cui, Y. Li, N. Irwin, D. Fischer, A. R. Harvey, and L. I. Benowitz. 2003. Macrophage-derived factors stimulate optic nerve regeneration. J. Neurosci. 23: 2284-2293.
32. Hübel, K., W. C. Liles, H. E. Broxmeyer, E. Rodger, B. Wood, S. Cooper, G. Hangoc, R. Macfarland, G. J. Bridger, G. W. Henson, et al. 2004. Leukocytosis and mobilization of CD34+ hematopoietic progenitor cells by AMD3100, a CXCR4 antagonist. Support. Cancer Ther. 1: 165-172.
33. Capoccia, B. J., R. M. Shepherd, and D. C. Link. 2006. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood 108: 2438-2445.
34. Lim, J. K., A. Lisco, D. H. McDermott, L. Huynh, J. M. Ward, B. Johnson, H. Johnson, J. Pape, G. A. Foster, D. Krysztof, et al. 2009. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog. 5: e1000321.
35. Mashimo, T., M. Lucas, D. Simon-Chazottes, M. P. Frenkiel, X. Montagutelli, P. E. Ceccaldi, V. Deubel, J. L. Guenet, and P. Despres. 2002. A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc. Natl. Acad. Sci. USA 99: 11311-11316.
36. Perelygin, A. A., S. V. Scherbik, I. B. Zhulin, B. M. Stockman, Y. Li, and M. A. Brinton. 2002. Positional cloning of the murine flavivirus resistance gene. Proc. Natl. Acad. Sci. USA 99: 9322-9327.
37. Modi, W. S., J. J. Goedert, S. Strathdee, S. Buchbinder, R. Detels, S. Donfield, S. J. O'Brien, and C. Winkler. 2003. MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission. AIDS 17: 2357-2365.
38. Smith, M. W., M. Dean, M. Carrington, C. Winkler, G. A. Huttley, D. A. Lomb, J. J. Goedert, T. R. O'Brien, L. P. Jacobson, R. Kaslow, et al. 1997. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277: 959-965.